Cargando…
Potent anti-tumor activity of CD45RA-targeting Hm3A4-Ranpirnase against myeloid lineage leukemias
CD45RA is a specific marker for leukemia stem cell (LSC) sub-populations in acute myeloid leukemia (AML). Ranpirnase (Rap), an amphibian RNase, has been extensively investigated in preclinical and clinical studies for its antitumor activity. Rap could be administered repeatedly to patients without i...
Autores principales: | Li, Sisi, Wang, Zhujun, Guo, Xiaoping, Chen, Ping, Tang, Yongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161826/ https://www.ncbi.nlm.nih.gov/pubmed/35322728 http://dx.doi.org/10.1080/21655979.2022.2054159 |
Ejemplares similares
-
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
por: Porta, Camillo, et al.
Publicado: (2008) -
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
por: Liu, Donglin, et al.
Publicado: (2014) -
Differential Expression of CD45RO and CD45RA in Bovine T Cells
por: Kandel, Anmol, et al.
Publicado: (2022) -
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
por: Li, Chenying, et al.
Publicado: (2020) -
CD45RA and CD45RBhigh expression induced by thymic selection events
Publicado: (1992)